NCT05546528

Brief Summary

The purpose of this trial is to evaluate the efficacy of photobiomodulation of the major salivary glands on salivary parameters in children with caries activity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 19, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

January 20, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2023

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

September 14, 2022

Last Update Submit

September 18, 2023

Conditions

Keywords

dental cariesphotobiomodulationsalivary flow

Outcome Measures

Primary Outcomes (1)

  • Salivary flow

    Saliva flow rate will be estimated by asking the children to salivate into the plastic cylinders (previously weighed) for 5 minutes. Next, these plastic cylinders (containing the saliva) will be weighed and the flow rate in g/ml will be calculated, which is equivalent to ml/min,

    three weeks

Secondary Outcomes (1)

  • Saliva pH

    three weeks

Study Arms (2)

photobiomodulation

EXPERIMENTAL

photobiomodulation application with the Laser Therapy XT device

Device: Photobiomodulation

photbiomodulation-sham

SHAM COMPARATOR

photobiomodulation application with the Laser Therapy XT device off

Device: Photobiomodulation- Sham

Interventions

G1 will receive the photobiomodulation application with the Laser Therapy XT device, (DMC, São Paulo, Brazil). The laser will be applied for 60 seconds per point, in 2 extraoral points and 2 intraoral points in the region of the parotid glands bilaterally, as well as 1 extraoral point for the submandibular and sublingual glands (totaling 16 points).

photobiomodulation

G2 will receive the photobiomodulation application with the Laser Therapy XT device off. The laser off will be applied for 60 seconds per point, in 2 extraoral points and 2 intraoral points in the region of the parotid glands bilaterally, as well as 1 extraoral point for the submandibular and sublingual glands (totaling 16 points).

photbiomodulation-sham

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may not qualify if:

  • Participants with severe active cavitated lesions with pulpal symptoms.
  • Plans of the family nucleus to move for the duration of the study.
  • Patients with a diagnosis of hyposalivation or xerostomia
  • Presence of fixed appliances.
  • Physical disability that interferes with oral or intellectual hygiene to answer the questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Magdalena San-Martín

Montevideo, Uruguay

RECRUITING

MeSH Terms

Conditions

Dental Caries

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Central Study Contacts

Lara J Motta, PhD

CONTACT

Magdalena San-Martín, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Only the researcher responsible for applying the laser will know which treatment was assigned to each participant. The researcher responsible for data collection will be blinded to the type of treatment received. The participant will be blind. The treatment with the control group will simulate the laser in operation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two groups: 1) the photobiomodulation experimental group (G1) , 2) the photobiomodulationn placebo group (G2) .
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 14, 2022

First Posted

September 19, 2022

Study Start

January 20, 2023

Primary Completion

July 30, 2023

Study Completion

November 20, 2023

Last Updated

September 21, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations